HS
Hardeep Singh
Also known as: Hardeep Pal Singh, Singh HP
Epicrispr Biotechnologies, 10X Genomics (United States), LV Prasad Eye Institute, Guru Nanak Dev University, Children's Hospital Los Angeles and USC Eye Institute
Employment
-
Epicrispr Biotechnologies Senior Scientist2023 - Present
-
10X Genomics (United States) Senior Scientist2021 - Present
-
Children's Hospital Los Angeles and USC Eye Institute Assistant Professor of Research Ophthalmology2019 - 2021
-
Children's Hospital of Los Angeles Post Doctoral Fellow2012 - 2019
-
Memorial Sloan-Kettering Cancer Center Post Doctoral Fellow2011 - 2012
-
University of Alberta Post Doctoral Fellow2009 - 2011
Education
-
LV Prasad Eye Institute PhD2004 - 2009
-
Guru Nanak Dev University Masters of Science2000 - 2002
Projects & Funding
Projects & funding information is unavailable.
Publications (24)
- Identification and characterization of early human photoreceptor states and cell-state-specific retinoblastoma-related features. Save
- An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma. Save
- Reciprocal Induction of MDM2 and MYCN in Neural and Neuroendocrine Cancers. Save
- A novel thyroid hormone receptor isoform, TRβ2-46, promotes SKP2 expression and retinoblastoma cell proliferation. Save
- Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors. Save
- Exploring the Retinoblastoma Origin with Fetal, Mouse, and hPSC-derived Retina Models Save
- Human Cone Precursor Circuitry Underlying Retinoblastoma Initiation Save
- Human Cone Precursor Program Underlying a Proliferative Response to pRB Loss Save
- Single-cell RNA-seq profiling of transcriptional transition states during human retinoblastoma development Save
- Rb suppresses human cone-precursor-derived retinoblastoma tumours Save